No Detail Found!

Vancomycin‑induced nephrotoxicity with unusual high serum trough level in a critically ill young patient

Author(s)
Yi Xin Cheng Department of Clinical Pharmacy, School of Pharmaceutical Sciences, Universiti Sains Malaysia,Penang,Malaysia
Chee Ping Chong Department of Clinical Pharmacy, School of Pharmaceutical Sciences, Universiti Sains Malaysia,Penang,Malaysia
Abstract
Vancomycin-induced nephrotoxicity (VIN) occurs more commonly in the elderly, and the reported serum trough levels seldom exceed 80 mg/L. We present a case of VIN with serum trough levels exceeding 100 mg/L in a critically ill young patient with initially normal kidney function. The patient was admitted to the Intensive Care Unit after a motor vehicle accident. Vancomycin was initiated for methicillin-resistant Staphylococcus aureus infection localized in his cerebrospinal fluid. Vancomycin was administered for another 16 days, during which the serum trough levels remained below 10 mg/L, and the renal function tests were normal. After an increment in the vancomycin dose on day 17 from 750 mg every 6 h to 1 g every 6 h, the patient developed acute kidney injury during which his vancomycin trough level was 110.73 mg/L. The acute kidney injury resolved approximately 2 weeks after the discontinuation of vancomycin therapy. The present case highlights that critically ill patients on prolonged vancomycin therapy should be closely monitored, and dose increments should be made cautiously regardless of whether the patient is of young age or has low serum trough levels or normal renal function.
Publication Details
Page(s) 106-109
Published Journal: Archives of Pharmacy Practice, Volume: 7, Issue: 3, Year: 2016

Request the full text from PASTIC

Keywords
vancomycin-induced nephrotoxicity, trough level, Acute Kidney Injury, critically ill
References
Barraclough K,Harris M,Montessori V,Levin A .2007 .An unusual case of acute kidney injury due to vancomycin lessons learnt from reliance on eGFR. Nephrol Dial Transplant, 22 : 2391-4.
Ladino M,Alex M,Mattiazzi A,Sadhu S,Schulman IH .2008 .Acute and reversible vancomycin nephrotoxicity: Case reports. J Nephrol Ren Transplant, 1 : 4-10.
Frimat L,Hestin D,Hanesse B,Cao‑Huu T,Kessler M. .1995 .Acute renal failure due to vancomycin alone. Nephrol Dial Transplant, 10 : 550-1.
Rybak M,Lomaestro B,Rotschafer JC,Moellering R,Craig W,Billeter M .2009 .Therapeutic monitoring of vancomycin in adult patients: A consensus review of the American Society of Health‑System Pharmacists, the Infectious Diseases Society of America, and the Society of Infectious Diseases Pharmacists. Am J Health Syst Pharm, 66 : 82-98.
Naranjo CA,Busto U,Sellers EM,Sandor P,Ruiz I,Roberts EA .1981 .A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther, 30 : 239-45.
Elyasi S,Khalili H,DashtiK‑havidaki S,Mohammadpour A .2012 .Vancomycini‑nduced nephrotoxicity: Mechanism, incidence, risk factors and special populations. A literature review. Eur J Clin Pharmacol, 68 : 12435-5.
Oktem F,Arslan MK,Ozguner F,Candir O,Yilmaz HR,Ciris M .2005 .In vivo evidences suggesting the role of oxidative stress in pathogenesis of vancomycin‑induced nephrotoxicity: Protection by erdosteine. Toxicology, 215 : 227-33.
Pannu N,Nadim MK .2008 .An overview of drug‑induced acute kidney injury. Crit Care Med, : S216-23.
Cataldo MA,Tacconelli E,Grilli E,Pea F,Petrosillo N. .2012 .Continuous versus intermittent infusion of vancomycin for the treatment of Gramp‑ositive infections: Systematic review and meta‑analysis. J Antimicrob Chemother, 67 : 17-24.
0

Citations

0

Downloads

11

Views